Urinary proteomics aids early ID of diabetic nephropathy

Urinary proteomics aids early ID of diabetic nephropathy
A biomarker classifier in urine can allow early detection of progression to diabetic nephropathy years before onset of macroalbuminuria, according to a study published online Aug. 7 in Diabetes.

(HealthDay) -- A biomarker classifier in urine can allow early detection of progression to diabetic nephropathy years before onset of macroalbuminuria, according to a study published online Aug. 7 in Diabetes.

Petra Zürbig, Ph.D., from Mosaiques Diagnostics in Hannover, Germany, and colleagues profiled the low-molecular weight proteome in the of 35 patients with type 1 and type 2 using a previously generated biomarker classifier of chronic kidney disease.

The researchers found that, compared with routine diagnosis using urinary albumin, application of the classifier to normoalbuminuric patients up to five years before the onset of macroalbuminuria allowed early detection of subsequent progression to macroalbuminuria (area under the curve, 0.93 versus 0.67). In particular, there was a decrease in collagen fragments three to five years before the development of macroalbuminuria.

"Urinary proteomics enables noninvasive assessment of risk at an early stage via determination of specific collagen fragments," Zürbig and colleagues conclude.

Several authors disclosed financial ties to pharmaceutical companies and/or Mosaiques Diagnostics, which developed and established the capillary electrophoresis coupled to mass spectrometry proteome analysis of human urine.

More information: Abstract
Full Text (subscription or payment may be required)

add to favorites email to friend print save as pdf

Related Stories

Uric acid may provide early clues to diabetic kidney disease

Mar 18, 2008

For patients with type 1 diabetes, increased levels of uric acid in the blood may be an early sign of diabetic kidney disease—appearing before any significant change in urine albumin level, the standard screening test, ...

Diabetics are not benefiting from advances in kidney care

Feb 24, 2011

Despite significant advances in kidney care over the past 20 years, efforts to improve therapy for type 1 diabetes patients with kidney dysfunction remain unsuccessful, according to a study appearing in an upcoming issue ...

Recommended for you

Blood glucose levels set for achieving HbA1c targets

Apr 11, 2014

(HealthDay)—The average self-monitored blood glucose (SMBG) concentrations needed at premeal, postmeal, and bedtime have been established to achieve a range of hemoglobin A1c (HbA1c) targets, according ...

Women with diabetes less likely to have a mammogram

Apr 11, 2014

Women with diabetes are 14 per cent less likely to be screened for breast cancer compared to women without diabetes, according to a study by researchers at the Institute for Clinical Evaluative Sciences (ICES) and Women's ...

User comments